Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis

Journal of Medicinal Chemistry

Volumn 46, Issue 16, 2003, Pages 3452-3454

  Zhou, Guochun ^a   Tsai, Chiawei W ^a   Liu, Jun O ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; EPOXIDE; FUMAGALONE; FUMAGILLIN; FUMAGILLOL CHLOROACETYLCARBAMATE; METHIONINE AMINOPEPTIDASE TYPE 2; METHIONYL AMINOPEPTIDASE; NATURAL PRODUCT; OVALICIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; ASSAY; BINDING AFFINITY; CELL PROLIFERATION; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; INHIBITION KINETICS;

AMINOPEPTIDASES; ANGIOGENESIS INHIBITORS; ANIMALS; CATTLE; CELL DIVISION; CYCLOHEXANES; CYCLOHEXANONES; ENDOTHELIUM, VASCULAR; EPOXY COMPOUNDS; FATTY ACIDS, UNSATURATED; METALLOENDOPEPTIDASES; PROTEIN BINDING; SESQUITERPENES;

EID: 0042343842     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0341103     Document Type: Article

References (20)

1. Hanson, F. R.; Eble, T. E. An antiphage agent isolated from aspergillus sp. J. Bacteriol. 1949, 58, 527-529.
2. Sigg, H. P.; Weber, H. P. Isolation and structure elucidation of ovalicin. Helv. Chim. Acta 1968, 51, 1395-1408.
3. Ingber, D.; Fujita, T.; Kishmoto, S.; Sudo, K.; Kanamaru, T.; et al. Synthetic Analogues of Fumagillin That Inhibit Angiogenesis and Suppress Tumour Growth. Nature 1990, 348, 555-557.
4. Corey, E. J.; Guzman-Perez, A.; Noe, M. C. Short enantioselective synthesis of(-)-ovalicin, a potent inhibitor of angiogenesis, using substrate-enhanced catalytic asymmetric dihydroxylation. J. Am. Chem. Soc. 1994, 116, 12109-12110.
5. Kusaka, M.; Sudo, K.; Matsutani, E.; Kozai, Y.; Marui, S.; et al. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470. Br. J. Cancer 1993, 69, 212-216.
6. 1 phase of the cell cycle. Cancer Res. 1994, 54, 2073-2076.
7. Abe, J.; Zhou, W.; Takuwa, N.; Taguchi, J.; Kurokawa, K.; et al. A Fumagillin Derivative Angiogenesis Inhibitor, AGM-1470, Inhibits Activation of Cyclin-Dependent Kinases and Phosphorylation of Retinoblastoma Gene Product but Not Protein Tyrosyl Phosphorylation or Protooncogene Expression in Vascular Endothelial Cells. Cancer Res. 1994, 54, 3407-3412.
8. Hori, A.; Ikeyama, S.; Sudo, K. Suppression of cyclin D1 mRNA expression by the angiogenesis inhibitor TNP-470 (AGM-1470) in vascular endothelial cells. Biochem. Biophys. Res. Commun. 1994, 204, 1067-1073.
9. Griffith, E. C.; Su, Z.; Turk, B. E.; Chen, S.; Chang, Y.-W.; et al. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Chem. Biol. 1997, 4, 461-471.
10. Sin, N.; Meng, L.; Wang, M. Q. W.; Wen, J. J.; Bornmann, W. G.; et al. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 6099-6103.
11. Griffith, E. C.; Su, Z.; Niwayama, S.; Ramsay, C. A.; Chang, Y. H.; et al. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 15183-15188.
12. Liu, S.; Widom, J.; Kemp, C. W.; Crews, C. M.; Clardy, J. Structure of human methionine aminopeptidase-2 complexed with fumagillin. Science 1998, 282, 1324-1327.
13. Lowther, W. T.; McMillen, D. A.; Orville, A. M.; Matthews, B. W. The anti-angiogenic agent fumagillin covalently modifies a conserved active-site histidine in the Escherichia coli methionine aminopeptidase. Proc Natl Acad Sci U.S.A. 1998, 95, 12153-12157.
14. Zhang, Y.; Griffith, E. C.; Sage, J.; Jacks, T.; Liu, J. O. Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 6427-6432.
15. Yeh, J. R.; Mohan, R.; Crews, C. M. The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 12782-12787.
16. Placidi, L.; Cretton-Scott, E.; de Sousa, G.; Rahmani, R.; Placidi, M.; et al. Disposition and metabolism of the angiogenic moderator O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470) in human hepatocytes and tissue microsomes. Cancer Res. 1995, 55, 3036-3042.
17. Bhargava, P.; Marshall, J. L.; Rizvi, N.; Dahut, W.; Yoe, J.; et al. A phase I and pharmacokinetic study of TNP-470 administered weekly to patients with advanced cancer. Clin. Cancer Res. 1999, 5, 1989-1995.
18. Tarbell, D. S.; Carman, R. M.; Chapman, D. D.; Cremer, S. E.; Cross, A. D.; et al. The chemistry of fumagillin. J. Am. Chem. Soc. 1961, 83, 3096-3113.
19. Pummerer, R. Phenylsulphoxyacetic acid. II. Ber. Dtsch. Chem. Ges. 1910, 43, 1401-1412.
20. Horner, L. The reaction of carboxylic acid anhydrides with sulfoxides. Ann. Phys. Chem. Poggendorf 1960, 631, 198-199.